The editor-in-chief has retracted a study that plagiarized “a large number” of papers, but only three are listed in the notice. Here’s the notice for “In situ-forming hydrogels for sustained ophthalmic drug delivery,” by Basavaraj K. Nanjawade, F.V. Manvi, and A.S. Manjappa, three researchers at India’s KLES’s College of Pharmacy, JN Medical College Campus, Karnataka:
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
This article has been retracted at the request of the Editor-in-Chief.
The authors have plagiarized parts of a large number of previously published papers. The three most plagiarized papers are:
Advanced Drug Delivery Reviews 16 (1995) 3–19 http://dx.doi.org/10.1016/0169-409X(95)00010-5
European journal of Pharmaceutics and Biopharmaceutics 58 (2004) 409–426 http://dx.doi.org/10.1016/j.ejpb.2004.03.019
Advanced Drug Delivery Reviews 16 (1995) 51–60 http://dx.doi.org/10.1016/0169-409X(95)00015-Y
One of the conditions of submission of a paper for publication is that authors declare explicitly that their work is original and has not appeared in a publication elsewhere. Re-use of any data should be appropriately cited. As such this article represents a severe abuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.
The paper has been cited 81 times, according to Thomson Scientific’s Web of Knowledge. That’s quite a bit more than we typically see with plagiarized papers, and suggests that damage to the original authors’ work is more considerable than usual.